Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.6022
Abstract: BACKGROUND Metabolic disorders are a hallmark feature of cancer. However, the evidence for the causality of circulating metabolites to promote or prevent colorectal cancer (CRC) is still lacking. We performed a two-sample Mendelian randomization (MR)… read more here.
Keywords: mendelian randomization; crc; analysis; colorectal cancer ... See more keywords